These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8182271)
21. Simultaneous vaccination for hepatitis A and B. Flehmig B; Heinricy U; Pfisterer M J Infect Dis; 1990 May; 161(5):865-8. PubMed ID: 2157770 [TBL] [Abstract][Full Text] [Related]
22. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers. Midthun K; Ellerbeck E; Gershman K; Calandra G; Krah D; McCaughtry M; Nalin D; Provost P J Infect Dis; 1991 Apr; 163(4):735-9. PubMed ID: 1849160 [TBL] [Abstract][Full Text] [Related]
23. Immunogenicity of a hepatitis A virus vaccine. Flehmig B; Haage A; Pfisterer M J Med Virol; 1987 May; 22(1):7-16. PubMed ID: 3035082 [TBL] [Abstract][Full Text] [Related]
24. Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis. Shouval D; Ashur Y; Adler R; Lewis JA; Armstrong ME; Davide JP; McGuire B; Kuter B; Brown L; Miller W Vaccine; 1993; 11 Suppl 1():S9-14. PubMed ID: 8383390 [TBL] [Abstract][Full Text] [Related]
25. Safety, tolerability, and immunogenicity of an inactivated hepatitis A vaccine: effects of single and booster injections, and comparison to administration of immune globulin. Shouval D; Ashur Y; Adler R; Lewis JA; Miller W; Kuter B; Brown L; Nalin DR J Hepatol; 1993; 18 Suppl 2():S32-7. PubMed ID: 8182270 [TBL] [Abstract][Full Text] [Related]
26. Immunogenicity and reactogenicity of a combined hepatitis A/B candidate vaccine: first results. Kallinowski B; Bock HL; Clemens R; Theilmann L Liver; 1996 Aug; 16(4):271-3. PubMed ID: 8878000 [TBL] [Abstract][Full Text] [Related]
27. Immunogenicity of two versus three injections of inactivated hepatitis A vaccine in adults. Chen XQ; Bülbül M; de Gast GC; van Loon AM; Nalin DR; van Hattum J J Hepatol; 1997 Feb; 26(2):260-4. PubMed ID: 9059944 [TBL] [Abstract][Full Text] [Related]
28. A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccine. Green MS; Cohen D; Lerman Y; Sjogren M; Binn LN; Zur S; Slepon R; Robin G; Hoke C; Bancroft W Isr J Med Sci; 1994; 30(5-6):485-8. PubMed ID: 8034508 [TBL] [Abstract][Full Text] [Related]
29. Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A. Ellerbeck EF; Lewis JA; Nalin D; Gershman K; Miller WJ; Armstrong ME; Davide JP; Rhoad AE; McGuire B; Calandra G Vaccine; 1992; 10(10):668-72. PubMed ID: 1523877 [TBL] [Abstract][Full Text] [Related]
30. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children. Kanra G; Yalçin SS; Ceyhan M; Yurdakök K Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974 [TBL] [Abstract][Full Text] [Related]
31. Concurrent administration of inactivated hepatitis A vaccine with immune globulin in healthy adults. Walter EB; Hornick RB; Poland GA; Tucker R; Bland CL; Clements DA; Rhamstine CC; Jacobson RM; Brown L; Gress JO; Harris KE; Wiens BL; Nalin DR Vaccine; 1999 Mar; 17(11-12):1468-73. PubMed ID: 10195783 [TBL] [Abstract][Full Text] [Related]
32. Placebo-controlled efficacy study of hepatitis A vaccine in Valdivia, Chile. Riedemann S; Reinhardt G; Frösner GG; Ibarra H; Moraleda L; Hering V; Siegel F; Toledo C; Leon J; Gonzalez JL Vaccine; 1992; 10 Suppl 1():S152-5. PubMed ID: 1335650 [TBL] [Abstract][Full Text] [Related]
33. Determination of hepatitis A antibody response to vaccination by an enzyme immunoassay. Zuckerman JN; Powell L; Lequin RM; Zuckerman AJ J Virol Methods; 1996 Jan; 56(1):27-31. PubMed ID: 8690763 [TBL] [Abstract][Full Text] [Related]
34. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals. Sandman L; Davidson M; Krugman S J Infect Dis; 1995 Mar; 171 Suppl 1():S50-2. PubMed ID: 7876649 [TBL] [Abstract][Full Text] [Related]
35. Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults. Bruguera M; Bayas JM; Vilella A; Tural C; González A; Vidal J; Dal-Ré R; Salleras L Vaccine; 1996 Oct; 14(15):1407-11. PubMed ID: 8994314 [TBL] [Abstract][Full Text] [Related]
36. A two dose combined hepatitis A and B vaccine in Chinese youngsters. Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A J Med Virol; 1999 Sep; 59(1):1-4. PubMed ID: 10440800 [TBL] [Abstract][Full Text] [Related]
37. Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers. Wiedermann G; Ambrosch F; Kollaritsch H; Hofmann H; Kunz C; D'Hondt E; Delem A; André FE; Safary A; Stéphenne J Vaccine; 1990 Dec; 8(6):581-4. PubMed ID: 1965077 [TBL] [Abstract][Full Text] [Related]
38. Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine. Dagan R; Greenberg D; Goldenbertg-Gehtman P; Vidor E; Briantais P; Pinsk V; Athias O; Dumas R Vaccine; 1999 Apr; 17(15-16):1919-25. PubMed ID: 10217590 [TBL] [Abstract][Full Text] [Related]
39. [Protection of adolescents against hepatitis A]. Puntarić D; Baklaić Z; Ljubicíc M; Vodopija I Lijec Vjesn; 1996 Oct; 118(10):241-3. PubMed ID: 9132523 [TBL] [Abstract][Full Text] [Related]
40. A dose response study of hepatitis A vaccine in healthy adults who are > or = 30 years old and weigh > or = 77 kg. Bertino JS; Thoelen S; VanDamme P; Bryan JP; Becherer PR; Frey S; Hayden FG; Marcus LC; Parenti DM; Sperling M; Chan IS; Brown L; Nalin D J Infect Dis; 1998 Oct; 178(4):1181-4. PubMed ID: 9806056 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]